Form 8-K - Current report:
SEC Accession No. 0001558370-19-011660
Filing Date
2019-12-20
Accepted
2019-12-20 16:04:53
Documents
97
Period of Report
2019-12-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K osmt-20191220x8k.htm 8-K 56074
2 EX-23.1 osmt-20191220ex2311b2d08.htm EX-23.1 4407
3 EX-99.1 osmt-20191220ex991b49ccd.htm EX-99.1 2690687
  Complete submission text file 0001558370-19-011660.txt   13596170

Data Files

Seq Description Document Type Size
4 EX-101.INS osmt-20191220.xml EX-101.INS 3646737
5 EX-101.SCH osmt-20191220.xsd EX-101.SCH 73919
6 EX-101.CAL osmt-20191220_cal.xml EX-101.CAL 107806
7 EX-101.DEF osmt-20191220_def.xml EX-101.DEF 363657
8 EX-101.LAB osmt-20191220_lab.xml EX-101.LAB 704101
9 EX-101.PRE osmt-20191220_pre.xml EX-101.PRE 602039
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 191301318
SIC: 2834 Pharmaceutical Preparations